UBS Asset Management Americas Inc. Has $399,000 Position in Vascular Solutions, Inc. (VASC)

UBS Asset Management Americas Inc. Has $399,000 Position in Vascular Solutions, Inc. (VASC)

UBS Asset Management Americas Inc. increased its stake in shares of Vascular Solutions, Inc. (NASDAQ:VASC) by 20.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,263 shares of the medical device company’s stock after buying an additional 1,400 shares during the period. UBS Asset Management Americas Inc.’s holdings in Vascular Solutions were worth $399,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Vascular Solutions by 5.3% in the second quarter. Vanguard Group Inc. now owns 790,007 shares of the medical device company’s stock valued at $32,911,000 after buying an additional 39,808 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Vascular Solutions by 2.8% in the second quarter. Principal Financial Group Inc. now owns 122,236 shares of the medical device company’s stock valued at $5,092,000 after buying an additional 3,365 shares during the last quarter. Prudential Financial Inc. boosted its stake in shares of Vascular Solutions by 9.3% in the second quarter. Prudential Financial Inc. now owns 46,267 shares of the medical device company’s stock valued at $1,927,000 after buying an additional 3,920 shares during the last quarter. Nationwide Fund Advisors boosted its stake in shares of Vascular Solutions by 57.6% in the second quarter. Nationwide Fund Advisors now owns 49,212 shares of the medical device company’s stock valued at $2,050,000 after buying an additional 17,983 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Vascular Solutions by 37.0% in the second quarter. JPMorgan Chase & Co. now owns 5,131 shares of the medical device company’s stock valued at $214,000 after buying an additional 1,387 shares during the last quarter. Institutional investors own 81.43% of the company’s stock.

Vascular Solutions, Inc. (NASDAQ:VASC) opened at 55.85 on Friday. The company’s 50-day moving average price is $55.80 and its 200 day moving average price is $49.94. Vascular Solutions, Inc. has a 1-year low of $24.34 and a 1-year high of $57.15. The firm has a market cap of $979.22 million, a price-to-earnings ratio of 81.18 and a beta of 0.94.

Several equities analysts have recently commented on the company. Piper Jaffray Companies lowered Vascular Solutions from an “overweight” rating to a “neutral” rating in a research note on Monday, December 5th. Canaccord Genuity lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Monday, December 5th. Zacks Investment Research lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, December 28th. Needham & Company LLC lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Friday, December 2nd. Finally, Feltl & Co. lowered Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Friday, December 2nd. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $51.80.

In related news, VP Chad Kugler sold 1,849 shares of Vascular Solutions stock in a transaction on Thursday, December 22nd. The stock was sold at an average price of $55.70, for a total transaction of $102,989.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 6.90% of the company’s stock.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Want to see what other hedge funds are holding VASC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vascular Solutions, Inc. (NASDAQ:VASC).

Related posts

Leave a Comment